Thrombosis Research
Volume 126, Issue 4 , Pages 276-279 , October 2010

Venous thromboembolism in acutely ill hospitalized medical patients

  • Raquel Barba

      Affiliations

    • Servicio de Medicina Interna, Hospital Infanta Cristina, Parla, Madrid, Spain
    • Corresponding Author InformationCorresponding author. Hospital Infanta Cristina, Avenida 9 Junio nº 2, 28981, Parla, Madrid, Spain. Tel.: +34 911913555; fax: +34 911913292.
    • ,
  • Antonio Zapatero

      Affiliations

    • Servicio de Medicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain
    • ,
  • Juan E. Losa

      Affiliations

    • Servicio de Medicina Interna, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain
    • ,
  • Javier Marco

      Affiliations

    • Servicio de Medicina Interna, Hospital Clínico de San Carlos, Madrid, Spain
    • ,
  • Susana Plaza

      Affiliations

    • Servicio de Medicina Interna, Hospital Severo Ochoa, Leganés, Madrid, Spain
    • ,
  • Jesús Canora

      Affiliations

    • Servicio de Medicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain
    • ,
  • Jose Manuel Casas

      Affiliations

    • Servicio de Medicina Interna, Hospital Infanta Cristina, Parla, Madrid, Spain

Received 19 April 2010 ,Revised 29 June 2010 ,Accepted 30 June 2010.

References 

  1. Agnelli G, Sonaglia F. Prevention of venous thromboembolism. Thromb Res. 2000;97(1):V49–V62
  2. Geerts W, Bergqvist D, Graham FP, et al. Prevention of Venous Thromboembolism: American College of Chest PHysicians Evidence-Based Clinical Practive Guidelines (8th Edition). Chest. 2008;133(6):381S–453S
  3. Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med. 2004;164(9):963–968
  4. Francis CW. Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients. N Engl J Med. 2007;356(14):1438–1444
  5. Leizorovicz A, Cohen AT, Turpie AG, et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004;110(7):874–879
  6. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med. 1999;341(11):793–800
  7. Amin A, Stemkowski S, Lin J, et al. Thromboprophylaxis rates in US medical centers: success or failure?. J Thromb Haemost. 2007;5(8):1610–1616
  8. Cohen AT, Zaw HM, Alikhan R. Benefits of deep-vein thrombosis prophylaxis in the nonsurgical patient: The MEDENOX trial. Semin Hematol. 2001;38(2 Suppl 5):31–38
  9. Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the international medical prevention registry on venous thromboembolism. Chest. 2007;132(3):936–945
  10. Alikhan R, Spyropoulos AC. Epidemiology of venous thromboembolism in cardiorespiratory and infectious disease. Am J Med. 2008;121(11):935–942
  11. Anderson DR, O'Brien BJ. Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism. Pharmacoeconomics. 1997;12(1):17–29
  12. Anderson FA, Zayaruzny M, Heit JA, et al. Estimated annual numbers of US acute-care hospital patients at risk of venous thromboembolism. Am J Hematol. 2007;82:777–782
  13. Inpatient Quality Indicators Overview.AHRQ Quality Indicators. Agency for Healthcare Research and Quality,Rockville,MD. 2006.
  14. Agencia de Calidad del SNS. In: Validación de indicadores de calidad utilizados en el contexto internacional: indicadores de seguridad de pacientes e indicadores de hospitalización evitable. Ministerio Sanidad; 2008;
  15. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383
  16. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–619
  17. Monreal M, Kakkar AK, Caprini JA, et al. The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry. J Thromb Haemost. 2004;2(11):1892–1898
  18. Prandoni P. Acquired risk factors for venous thromboembolism in medical patients. Hematology Am Soc Hematol Educ Program. 2005;458–461
  19. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585–593
  20. Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151(5):933–938
  21. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585–593
  22. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160(6):809–815
  23. Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med. 2000;160(22):3415–3420
  24. Smeeth L, Cook C, Thomas S, et al. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet. 2006;367(9516):1075–1079
  25. Alikhan R, Syropoulus AC. Epidemiology of Venous Thromboembolism in Cardiorespiratory and Infectious Disease. Am J Med. 2008;121:935–942
  26. Elis A, Ellis MH. Preventing venous thromboembolism in acute medical patients. QJM. 2004;97(12):797–801
  27. Arnold DM, Kahn SR, Shrier I. Missed opportunities for prevention of venous thromboembolism: an evaluation of the use of thromboprophylaxis guidelines. Chest. 2001;120(6):1964–1971
  28. Kakkar AK, Davidson BL, Haas SK. Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines. J Thromb Haemost. 2004;2(2):221–227
  29. Monreal M, Kakkar AK, Caprini JA, et al. The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry. J Thromb Haemost. 2004;2(11):1892–1898
  30. Nieto JA. Riesgo de enfermedad tromboembólica venosa y profilaxis antitrombótica en los pacientes ingresados en hospitales españoles (estudio ENDORSE). Med Clin (Barc). 2009;133:1–7
  31. Guijarro R, Montes J, Sanroman C, et al. Venous thromboembolism in Spain. Comparison between and administrative database and the RIETE registry. Eur J Intern Med. 2008;19:443–446
  32. Barba R, Losa JE, Guijarro C, et al. Fiabilidad del CMBD en el diagnóstico de enfermedad tromboembólica. Med Clin (Barc). 2006;127(7):255–257
  33. Amin A, Stemkowski S, Lin J, et al. Thromboprophylaxis rates in US medical centers: success or failure?. J Thromb Haemost. 2007;5(8):1610–1616
  34. Cohen AT, Alikhan R, Arcelus JI, et al. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost. 2005;94(4):750–759
  35. Kakkar AK, Davidson BL, Haas SK. Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines. J Thromb Haemost. 2004;2(2):221–227
  36. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005;352(10):969–977
  37. Hull RD, Schellong SM, Tapson VF, et al. Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study. J Thromb Thrombolysis. 2006;22(1):31–38

☆ Summary findings from this study were presented as a poster in the Meeting of the National Internal Medicine Society, November 21st, 2009, Valencia, Spain.

PII: S0049-3848(10)00367-1

doi: 10.1016/j.thromres.2010.06.027

Thrombosis Research
Volume 126, Issue 4 , Pages 276-279 , October 2010

Article Tools